Protavio Ltd

Protavio Ltd is a leading multiplex proteomics company that began its journey in 2011, with the mission to enhance human health through innovative scientific advancements in the realm of proteomics. Over the last two decades, the Protavio team has cultivated an extensive expertise in multiplex assays, profoundly contributing to the development of diagnostic products designed to address complex health challenges. Their approach employs cutting-edge technologies that allow simultaneous analysis of a multitude of proteins, thus solving critical issues related to sample scarcity and high-throughput requirements.

At the core of Protavio's operations lies a commitment to excellence and quality management, guided by stringent GMP, ISO13485, and ISO9001 standards. The company specializes in providing advanced proteomic solutions that range from initial biomarker discovery to the eventual development and validation of diagnostic assays. Their facilities are equipped with state-of-the-art technology and bioinformatics systems, positioning Protavio at the forefront of innovation in the biotechnology sector. Furthermore, through its collaborative projects and expertise, Protavio is dedicated to translating scientific insights into tangible healthcare solutions that improve patient outcomes.